title: Stress activation of mammary epithelial cell xanthine oxidoreductase is mediated by p38 MAPK and CCAAT/enhancer-binding protein-beta.
abstract: Xanthine oxidoreductase (XOR) catalyzes the formation of uric acid from xanthine and hypoxanthine and is recognized as a source of reactive oxygen and nitrogen species. Unexpectedly, XOR was found to play an essential role in milk secretion in the differentiating mammary gland, where it is an integral component of the milk fat globule. XOR gene expression in both mammary glands and differentiating mammary epithelial cells in culture is regulated by the lactogenic hormones prolactin and cortisol. Expression in mammary epithelial cells is also regulated by inflammatory cytokines and induced by cycloheximide. Cycloheximide was found to stimulate XOR gene expression in differentiating HC11 mouse mammary epithelial cells. Activation of XOR gene expression by both cycloheximide and inflammatory cytokines suggested that XOR may be regulated by stress-activated protein kinases, the MAPKs. We demonstrate here that XOR was induced in HC11 cells by low dose cycloheximide and that expression was blocked by inhibitors of p38 MAPK. Accumulation of phospho-p38 was stimulated by low dose cycloheximide. Low dose cycloheximide stress promoted phosphorylation and nuclear accumulation of the CCAAT/enhancer-binding protein-beta (C/EBPbeta) transcription factor, which was blocked by inhibition of p38. Furthermore, C/EBPbeta was found to activate the mouse XOR promoter, and XOR promoter-C/EBPbeta protein complexes were induced by low dose cycloheximide stress. These data demonstrate, for the first time, that mouse mammary epithelial cell XOR is regulated by p38 MAPK. They identify an essential function of the C/EBPbeta transcription factor in mouse XOR expression and suggest a potential role for p38 MAPK activation of C/EBPbeta in mammary epithelial cells.
authors.affiliation: Department of Biochemistry, University of Bath, Bath BA2 7AY, United Kingdom.
authors.forename: Katherine J
authors.initials: KJ
authors.lastname: Seymour
authors.forename: Laura E
authors.initials: LE
authors.lastname: Roberts
authors.forename: Mehdi A
authors.initials: MA
authors.lastname: Fini
authors.forename: Lisa A
authors.initials: LA
authors.lastname: Parmley
authors.forename: Tatiana L
authors.initials: TL
authors.lastname: Oustitch
authors.forename: Richard M
authors.initials: RM
authors.lastname: Wright
mesh_terms: D000818:Animals; D001665:Binding Sites; D015153:Blotting, Western; D022782:CCAAT-Enhancer-Binding Protein-beta / Q000378:metabolism*; D018929:Cell Culture Techniques; D002460:Cell Line; D002467:Cell Nucleus / Q000378:metabolism; D047369:Chromatin Immunoprecipitation; D003513:Cycloheximide / Q000494:pharmacology; D004591:Electrophoresis, Polyacrylamide Gel; D024202:Electrophoretic Mobility Shift Assay; D004790:Enzyme Induction / Q000187:drug effects; D004847:Epithelial Cells / Q000201:enzymology*; D005260:Female; D017930:Genes, Reporter; D008156:Luciferases / Q000378:metabolism; D008321:Mammary Glands, Animal / Q000166:cytology*; D051379:Mice; D016297:Mutagenesis, Site-Directed; D009154:Mutation; D011401:Promoter Regions, Genetic; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D013312:Stress, Physiological / Q000378:metabolism*; D014162:Transfection; D014968:Xanthine Dehydrogenase / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism*; D048051:p38 Mitogen-Activated Protein Kinases / Q000378:metabolism*
chemical_list: D022782:CCAAT-Enhancer-Binding Protein-beta; D011500:Protein Synthesis Inhibitors; D003513:Cycloheximide; D008156:Luciferases; D014968:Xanthine Dehydrogenase; D048051:p38 Mitogen-Activated Protein Kinases